<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>
<!-- TitleColor	News Story Title Color	(R,G,B)	(0,0,0)
TitleSize	News Story Title Size	(Number)	14
TitleFont	News Story Title Font	(Text)	Courier
DescriptionColor	News Story Description Color	(R,G,B)	(0,0,0)
DescriptionSize	News Story Description Size	(Number)	14
DescriptionFont	News Story Description Font	(Text)	Courier
TitleTextBGColor	News Story Color Background of the Text	(R,G,B)	-255,255,255
TitleTextBGAlpha	News Story Alpha for Background of the Text 	(1-100)	80
linkSafari	if to open link in Safri?	(Text)	yes/no/stop	yes is default
cellType	cell type	(Number)	1 ot 2, 1 is for the old cell type 2 for the new	2 is default
oldShare	return to the old share?	(Boolean)	true/false - return to the old share style	false is default
 -->

<channel>
	<title>World Israel NewsRelivion Archives - World Israel News</title>
	<atom:link href="https://worldisraelnews.com/tag/relivion/feed/" rel="self" type="application/rss+xml" />
	<link>https://worldisraelnews.com/tag/relivion/</link>
	<description>Latest News from Israel and the World</description>
	<lastBuildDate>Sat, 25 Jul 2026 21:56:19 +0000</lastBuildDate>
	<language>en-US</language>
	<bgcolor>(63,188,253)</bgcolor>
	<iphoneHeight>220</iphoneHeight>
	<ipadHeight>300</ipadHeight>
	<TitleColor>(255,255,255)</TitleColor>

	<!-- News Story Title Color	(R,G,B)	(0,0,0) -->
	<TitleSize>16</TitleSize>
	<!-- News Story Title Size	(Number)	14 -->
	<TitleFont>Helvetica</TitleFont>
	<!-- News Story Title Font	(Text)	Courier -->
	<DescriptionColor>(255,255,255)</DescriptionColor>
	<!-- News Story Description Color	(R,G,B)	(0,0,0) -->
	<DescriptionSize>14</DescriptionSize>
	<!-- News Story Description Size	(Number)	14 -->
	<DescriptionFont>Helvetica</DescriptionFont>
	<!-- News Story Description Font	(Text)	Courier -->
	<TitleTextBGColor>(90,90,90)</TitleTextBGColor>
	<!-- News Story Color Background of the Text	(R,G,B)	-255,255,255 -->
	<TitleTextBGAlpha>80</TitleTextBGAlpha>
	<!-- News Story Alpha for Background of the Text 	(1-100)	80 -->
	<linkSafari>no</linkSafari>
	<ShareTrigger>30</ShareTrigger>
	<RateTrigger>120</RateTrigger>
	<InitialPostsAmount>30</InitialPostsAmount>
	<!-- linkSafari	if to open link in Safari?	(Text)	yes/no/stop	yes is default -->
	<!-- <cellType>no</cellType> -->
	<!-- cell type	(Number)	1 or 2, 1 is for the old cell type 2 for the new	2 is default -->
	<!-- <cellType>oldShare</cellType> -->
	<!-- return to the old share?	(Boolean)	true/false - return to the old share style	false is default -->



		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>WATCH: Revolutionary Israeli treatment for migraines gets European approval</title>
		<link>https://worldisraelnews.com/watch-revolutionary-israeli-treatment-for-migraines-gets-european-approval/</link>
		<comments>https://worldisraelnews.com/watch-revolutionary-israeli-treatment-for-migraines-gets-european-approval/#respond</comments>
		<pubDate>Sun, 28 Jul 2019 09:36:29 +0000</pubDate>
		<dc:creator><![CDATA[Atara Beck]]></dc:creator>
				<category><![CDATA[Israeli Innovation & Technology]]></category>
		<category><![CDATA[Videos]]></category>
		<category><![CDATA[Israeli heathcare]]></category>
		<category><![CDATA[Israeli medical technology]]></category>
		<category><![CDATA[Israeli startup]]></category>
		<category><![CDATA[Neurolief]]></category>
		<category><![CDATA[Relivion]]></category>

		<guid isPermaLink="false">https://worldisraelnews.com/?p=172755</guid>
				<description><![CDATA[<p>Neurolief, an Israeli startup, has recently received European approval for its non-invasive, adjustable electronic headset, which uses nerve stimulation to control pain.</p>
<p>The post <a href="https://worldisraelnews.com/watch-revolutionary-israeli-treatment-for-migraines-gets-european-approval/">WATCH: Revolutionary Israeli treatment for migraines gets European approval</a> appeared first on <a href="https://worldisraelnews.com">World Israel News</a>.</p>
]]></description>
				<content:encoded><![CDATA[<img fetchpriority="high" decoding="async" width="846" height="427" src="https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2.jpg" class="attachment-uwi-content-loop size-uwi-content-loop wp-post-image" alt="" /><p>Neurolief, an Israeli startup, has recently received European approval for its non-invasive, adjustable electronic headset, which uses nerve stimulation to control pain, <em>Calcalist</em> reports.</p>
<div class="a-single a-30">
<div class="desktop g-ad show-in-video" style="margin-bottom: 20px;">
<!-- DT_NOvideo_belowtitle --><br />
<ins class="adsbygoogle"
     style="display:block;width:100%;min-height:50px;"
     data-ad-client="ca-pub-3367304846618890"
     data-ad-slot="7998477368"
     data-ad-format="auto"></ins><br />
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script>
</div>
</div>
<div style="margin: 10px 0;width: 100%;"><iframe title="The Relivion   How it works" width="750" height="422" src="https://www.youtube.com/embed/_X_sTdOFiz0?feature=oembed" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe></div>
<p><!-- Error, Advert is not available at this time due to schedule/geolocation restrictions! --></p>
<p>The post <a href="https://worldisraelnews.com/watch-revolutionary-israeli-treatment-for-migraines-gets-european-approval/">WATCH: Revolutionary Israeli treatment for migraines gets European approval</a> appeared first on <a href="https://worldisraelnews.com">World Israel News</a>.</p>
]]></content:encoded>
			<wfw:commentRss>https://worldisraelnews.com/watch-revolutionary-israeli-treatment-for-migraines-gets-european-approval/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<post_id>172755</post_id><featured_image>https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2.jpg</featured_image><featured_image_resized>https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2-846x400.jpg</featured_image_resized><uwi-featured-carousel>https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2-846x400.jpg</uwi-featured-carousel><uwi-featured-content>https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2-290x160.jpg</uwi-featured-content><featured_image_iphone>https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2.jpg</featured_image_iphone><featured_image_iphone_2>https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2.jpg</featured_image_iphone_2><featured_image_ipad>https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2.jpg</featured_image_ipad><featured_image_ipad_2>https://worldisraelnews.com/wp-content/uploads/2019/07/Relivion-Migraine-treatment.v2.jpg</featured_image_ipad_2><ad_label></ad_label><ad_font_color></ad_font_color><ad_font_size></ad_font_size><ad_font_family></ad_font_family><ad_link></ad_link>	</item>
	</channel>
</rss>
